The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
The EGFRvIII variant in glioblastoma multiforme
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Wen, P. Y., & Kesari, S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0708126 · Cited by 3,511
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
Boise, L. H., González-García, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nuñez, G., & Thompson, C. B. (1993) · Cell · doi:10.1016/0092-8674(93)90508-n · Cited by 3,087
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences
Downward, J., Yarden, Y., Mayes, E., Scrace, G., Totty, N., Stockwell, P., Ullrich, A., Schlessinger, J., & Waterfield, M. D. (1984) · Nature · doi:10.1038/307521a0 · Cited by 2,516
Olayioye, M. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3159 · Cited by 2,434
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
Cohen, S. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83739-0 · Cited by 2,193
Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells
Al-Nedawi, K., Meehan, B., Micallef, J., Lhotak, V., May, L., Guha, A., & Rak, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1725 · Cited by 2,034
Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
Tyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
The WHO classification of tumors of the nervous system
Kleihues, P., Louis, D. N., Scheithauer, B. W., Rorke, L. B., Reifenberger, G., Burger, P. C., & Cavenee, W. K. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.215 · Cited by 1,547
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
Mellinghoff, I. K., Wang, M. Y., Vivanco, I., Haas-Kogan, D. A., Zhu, S., Dia, E. Q., Lu, K. V., Yoshimoto, K., Huang, J. H. Y., Chute, D. J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051918 · Cited by 1,442
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
Schechter, A. L., Stern, D. F., Vaidyanathan, L., Decker, S. J., Drebin, J. A., Greene, M. I., & Weinberg, R. A. (1984) · Nature · doi:10.1038/312513a0 · Cited by 1,175
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Stommel, J. M., Kimmelman, A. C., Ying, H., Nabioullin, R., Ponugoti, A. H., Wiedemeyer, R., Stegh, A. H., Bradner, J. E., Ligon, K. L., Brennan, C., et al. (2007) · Science · doi:10.1126/science.1142946 · Cited by 938
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., & Huang, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7727 · Cited by 936
Structural alterations of the epidermal growth factor receptor gene in human gliomas.
Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., & Vogelstein, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2965 · Cited by 853
Specificity within the EGF family/ErbB receptor family signaling network
Riese, D. J., & Stern, D. F. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199801)20:1<41::aid-bies7>3.0.co;2-v · Cited by 809
Phase II Trial of Gefitinib in Recurrent Glioblastoma
Rich, J. N., Reardon, D. A., Peery, T., Dowell, J. M., Quinn, J. A., Penne, K. L., Wikstrand, C. J., Van Duyn, L. B., Dancey, J. E., McLendon, R. E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.110 · Cited by 734
Ekstrand, A. J., James, C. D., Cavenee, W. K., Seliger, B., Pettersson, R. F., & Collins, V. P. (1991) · PubMed · Cited by 719
Plowman, G. D., Culouscou, J. M., Whitney, G. S., Green, J. M., Carlton, G. W., Foy, L., Neubauer, M. G., & Shoyab, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1746 · Cited by 713
Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
Shinojima, N., Tada, K., Shiraishi, S., Kamiryo, T., Kochi, M., Nakamura, H., Makino, K., Saya, H., Hirano, H., Kuratsu, J., et al. (2003) · PubMed · Cited by 663
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target
Horvath, S., Zhang, B., Carlson, M., Lu, K. V., Zhu, S., Felciano, R. M., Laurance, M. F., Zhao, W., Qi, S., Chen, Z., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608396103 · Cited by 641
Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors.
Moscatello, D. K., Holgado-Madruga, M., Godwin, A. K., Ramirez, G., Gunn, G. R., Zoltick, P. W., Biegel, J. A., Hayes, R. L., & Wong, A. J. (1995) · PubMed · Cited by 637
Ekstrand, A. J., Sugawa, N., James, C. D., & Collins, V. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4309 · Cited by 602
Huang, H.-J. S., Nagane, M., Klingbeil, C. K., Lin, H., Nishikawa, R., Ji, X.-D., Huang, C.-M., Gill, G. N., Wiley, H. S., & Cavenee, W. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2927 · Cited by 595
Sugawa, N., Ekstrand, A. J., James, C. D., & Collins, V. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8602 · Cited by 594
Rude Voldborg, B., Damstrup, L., Spang-Thomsen, M., & Skovgaard Poulsen, H. (1997) · Annals of Oncology · doi:10.1023/a:1008209720526 · Cited by 528
Wikstrand, C. J., Hale, L. P., Batra, S. K., Hill, M. L., Humphrey, P. A., Kurpad, S. N., McLendon, R. E., Moscatello, D. K., Pegram, C. N., & Reist, C. J. (1995) · PubMed · Cited by 518
Heimberger, A. B., Hlatky, R., Suki, D., Yang, D., Weinberg, J., Gilbert, M., Sawaya, R., & Aldape, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1737 · Cited by 516
Expression of epidermal growth factor receptors in human brain tumors.
Libermann, T. A., Razon, N., Bartal, A. D., Yarden, Y., Schlessinger, J., & Soreq, H. (1984) · PubMed · Cited by 473
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib
Haas-Kogan, D. A., Prados, M. D., Tihan, T., Eberhard, D. A., Jelluma, N., Arvold, N. D., Baumber, R., Lamborn, K. R., Kapadia, A., Malec, M., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji161 · Cited by 465
Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro
CARPENTER, G., KING, L., & COHEN, S. (1978) · Nature · doi:10.1038/276409a0 · Cited by 454
Surawicz, T. S., McCarthy, B. J., Kupelian, V. A., Jukich, P. J., Bruner, J. M., & Davis, F. G. (1999) · Neuro-Oncology · doi:10.1093/neuonc/1.1.14 · Cited by 443
Nagane, M., Coufal, F. J., Lin, H., Bögler, O., Cavenee, W. K., & Huang, H.-J. S. (1996) · PubMed · Cited by 405
Huang, P. H., Mukasa, A., Bonavia, R., Flynn, R. A., Brewer, Z. E., Cavenee, W. K., Furnari, F. B., & White, F. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705158104 · Cited by 390
Molecular cloning and expression of an additional epidermal growth factor receptor-related gene.
Plowman, G. D., Whitney, G. S., Neubauer, M. G., Green, J. M., McDonald, V. L., Todaro, G. J., & Shoyab, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.4905 · Cited by 366
Nagane, M., Levitzki, A., Gazit, A., Cavenee, W. K., & Huang, H.-J. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5724 · Cited by 363
Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts.
Bigner, S. H., Humphrey, P. A., Wong, A. J., Vogelstein, B., Mark, J., Friedman, H. S., & Bigner, D. D. (1990) · PubMed · Cited by 331
Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion.
Lal, A., Glazer, C. A., Martinson, H. M., Friedman, H. S., Archer, G. E., Sampson, J. H., & Riggins, G. J. (2002) · PubMed · Cited by 311
Pelloski, C. E., Ballman, K. V., Furth, A. F., Zhang, L., Lin, E., Sulman, E. P., Bhat, K., McDonald, J. M., Yung, W. K. A., Colman, H., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.0705 · Cited by 311
Aldape, K. D., Ballman, K., Furth, A., Buckner, J. C., Giannini, C., Burger, P. C., Scheithauer, B. W., Jenkins, R. B., & James, C. D. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.7.700 · Cited by 278
Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas.
de Palazzo, I. G., Adams, G. P., Sundareshan, P., Wong, A. J., Testa, J. R., Bigner, D. D., & Weiner, L. M. (1993) · PubMed · Cited by 269
Wang, M. Y., Lu, K. V., Zhu, S., Dia, E. Q., Vivanco, I., Shackleford, G. M., Cavenee, W. K., Mellinghoff, I. K., Cloughesy, T. F., Sawyers, C. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-4392 · Cited by 240
Heimberger, A. B., Alexander, L. E. C., Archer, G. E., Hess, K. R., Wikstrand, C. J., Friedman, A. H., Friedman, H. S., Bigner, D. D., & Sampson, J. H. (2003) · PubMed · Cited by 234
Feldkamp, M. M., Feldkamp, M. M., Lala, P., Lau, N., Roncari, L., Guha, A., Guha, A., & Guha, A. (1999) · Neurosurgery · doi:10.1097/00006123-199912000-00034 · Cited by 227
Scott, A. M., Lee, F.-T., Tebbutt, N., Herbertson, R., Gill, S. S., Liu, Z., Skrinos, E., Murone, C., Saunder, T. H., Chappell, B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611693104 · Cited by 222
Yamazaki, H., Fukui, Y., Ueyama, Y., Tamaoki, N., Kawamoto, T., Taniguchi, S., & Shibuya, M. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.4.1816 · Cited by 212
Franceschi, E., Cavallo, G., Lonardi, S., Magrini, E., Tosoni, A., Grosso, D., Scopece, L., Blatt, V, Urbini, B., Pession, A., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603669 · Cited by 211
Mishima, K., Johns, T. G., Luwor, R. B., Scott, A. M., Stockert, E., Jungbluth, A. A., Ji, X.-D., Suvarna, P., Voland, J. R., Old, L. J., et al. (2001) · PubMed · Cited by 204
Self-citationLessons learned in the development of targeted therapy for malignant gliomas
Omuro, A. M. P., Faivre, S., & Raymond, E. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0047 · Cited by 196
Narita, Y., Nagane, M., Mishima, K., Huang, H.-J. S., Furnari, F. B., & Cavenee, W. K. (2002) · PubMed · Cited by 189
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors
Sampson, J. H., Crotty, L. E., Lee, S., Archer, G. E., Ashley, D. M., Wikstrand, C. J., Hale, L. P., Small, C., Dranoff, G., Friedman, A. H., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130166597 · Cited by 188
EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes
Grandal, M. V., Zandi, R., Pedersen, M. W., Willumsen, B. M., van Deurs, B., & Poulsen, H. S. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm058 · Cited by 179
Ramos, T. C., Figueredo, J., Cataĺa, M., Sandra, G., Selva, J. C., Cruz, T. M., Toledo, C., Silva, S., Pestano, Y., Ramos, M., et al. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.4.2522 · Cited by 176
Prigent, S. A., Nagane, M., Lin, H., Huvar, I., Boss, G. R., Feramisco, J. R., Cavenee, W. K., & Huang, H.-J. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25639 · Cited by 175
Jungbluth, A. A., Stockert, E., Huang, H. J. S., Collins, V. P., Coplan, K., Iversen, K., Kolb, D., Johns, T. J., Scott, A. M., Gullick, W. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232686499 · Cited by 174
Learn, C. A., Hartzell, T. L., Wikstrand, C. J., Archer, G. E., Rich, J. N., Friedman, A. H., Friedman, H. S., Bigner, D. D., & Sampson, J. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0521 · Cited by 173
Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma
Sampson, J. H., Archer, G. E., Mitchell, D. A., Heimberger, A. B., & Bigner, D. D. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.04.001 · Cited by 172
Mizoguchi, M., Betensky, R. A., Batchelor, T. T., Bernay, D. C., Louis, D. N., & Nutt, C. L. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000248549.14962.b2 · Cited by 171
Heimberger, A. B., Learn, C. A., Archer, G. E., McLendon, R. E., Chewning, T. A., Tuck, F. L., Pracyk, J. B., Friedman, A. H., Friedman, H. S., Bigner, D. D., et al. (2002) · PubMed · Cited by 169
Glycosylation-induced Conformational Modification Positively Regulates Receptor-Receptor Association
Fernandes, H., Cohen, S., & Bishayee, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005599200 · Cited by 160
Malden, L. T., Novak, U., Kaye, A. H., & Burgess, A. W. (1988) · PubMed · Cited by 156
Self-citationIntegrins: Molecular determinants of glioma invasion
D’Abaco, G. M., & Kaye, A. H. (2007) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2007.06.019 · Cited by 153
Self-citationJohns, T. G., Adams, T. E., Cochran, J. R., Hall, N. E., Hoyne, P. A., Olsen, M. J., Kim, Y., Rothacker, J., Nice, E. C., Walker, F., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401218200 · Cited by 150
Ge, H., Gong, X., & Tang, C. K. (2002) · International Journal of Cancer · doi:10.1002/ijc.10224 · Cited by 135
Johns, T. G., Stockert, E., Ritter, G., Jungbluth, A. A., Huang, H.-J. S., Cavenee, W. K., Smyth, F. E., Hall, C. M., Watson, N., Nice, E. C., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10189 · Cited by 134
Fry, D. W. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00050-3 · Cited by 129
Wu, G. J., Yang, W., Barth, R. F., Kawabata, S., Swindall, M., Bandyopadhyaya, A. K., Tjarks, W., Khorsandi, B., Blue, T. E., Ferketich, A. K., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2399 · Cited by 121
Montgomery, B., Guzman, J., O’Rourke, D. M., & Stahl, W. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000966200 · Cited by 115
Yang, W., Wu, G. J., Barth, R. F., Swindall, M., Bandyopadhyaya, A. K., Tjarks, W., Tordoff, K. P., Moeschberger, M. L., Sferra, T. J., Binns, P. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1968 · Cited by 108
Liu, L., Bäcklund, L. M., Nilsson, B. R., Grandér, D., Ichimura, K., Goike, H. M., & Collins, V. P. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0700-2 · Cited by 108
Johns, T. G., Luwor, R. B., Murone, C., Walker, F., Weinstock, J., Vitali, A. A., Perera, R. M., Jungbluth, A. A., Stockert, E., Old, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036503100 · Cited by 107
Self-citationTargeting malignant glioma survival signalling to improve clinical outcomes
Wong, M. L. H., Kaye, A. H., & Hovens, C. M. (2007) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2006.11.005 · Cited by 103
Self-citationPerera, R. M., Narita, Y., Furnari, F. B., Gan, H. K., Murone, C., Ahlkvist, M., Luwor, R. B., Burgess, A. W., Stockert, E., Jungbluth, A. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2653 · Cited by 103
Self-citationYang, W., Barth, R. F., Wu, G. J., Kawabata, S., Sferra, T. J., Bandyopadhyaya, A. K., Tjarks, W., Ferketich, A. K., Moeschberger, M. L., Binns, P. J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0141 · Cited by 103
Moscatello, D. K., Ramirez, G., & Wong, A. J. (1997) · PubMed · Cited by 88
Johns, T. G., Perera, R. M., Vernes, S. C., Vitali, A. A., Cao, D. X., Cavenee, W. K., Scott, A. M., & Furnari, F. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1453 · Cited by 84
Nagane, M., Narita, Y., Mishima, K., Levitzki, A., Burgess, A. W., Cavenee, W. K., & Huang, H. (2001) · Journal of neurosurgery · doi:10.3171/jns.2001.95.3.0472 · Cited by 83
EGFR tyrosine kinase domain mutations in human gliomas
Marie, Y., Carpentier, A. F., Omuro, A. M. P., Sanson, M., Thillet, J., Hoang‐Xuan, K., & Delattre, J. (2005) · Neurology · doi:10.1212/01.wnl.0000158654.07080.b0 · Cited by 79
Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII
Han, W., Zhang, T., Yu, H. W., Foulke, J. G., & Tang, C. K. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.10.3226 · Cited by 77
Frederick, L. A., Eley, G. D., Wang, X.-Y., & James, C. D. (2000) · Neuro-Oncology · doi:10.1093/neuonc/2.3.159 · Cited by 76
EGF receptor variant III as a target antigen for tumor immunotherapy
Li, G., & Wong, A. J. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.7.977 · Cited by 74
Vogelbaum, M. A., Peereboom, D. M., Stevens, G. H. J., Barnett, G. H., & Brewer, C. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.1558 · Cited by 72
EGFRMutations and Sensitivity to Gefitinib
Rossi, G., Marchioni, A., & Longo, L. (2004) · New England Journal of Medicine · doi:10.1056/nejm200409163511221 · Cited by 72
Cemeus, C., Zhao, T., Barrett, G. M., Lorimer, I. A. J., & Dimitroulakos, J. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9627-0 · Cited by 63
Pedersen, M. W., Pedersen, N. M., Damstrup, L., Villingshøj, M., Sønder, S. U., Rieneck, K., Bovin, L. F., Spang‐Thomsen, M., & Poulsen, H. S. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20554 · Cited by 62
NABTC phase I/II trial of ZD-1839 for recurrent malignant gliomas and unresectable meningiomas
Lieberman, F. S., Cloughesy, T. F., Fine, H. A., Kuhn, J. G., Lamborn, K. R., Malkin, M. G., Robbins, H. I., Yung, W. A., Wen, P. Y., & Prados, M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.1510 · Cited by 58
Klingler‐Hoffmann, M., Bukczynska, P. E., & Tiganis, T. (2003) · International Journal of Cancer · doi:10.1002/ijc.11085 · Cited by 47
Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge
Soni, D., King, J. A. J., Kaye, A. H., & Hovens, C. M. (2005) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.04.001 · Cited by 43
Self-citationRobins, H. I., Wen, P. Y., Chang, S., Kuhn, J. G., Lamborn, K. R., Cloughesy, T. F., Glibert, M. R., Yung, W. K. A., Dancey, J. E., & Prados, M. D. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.2057 · Cited by 42
Activation of extracellular-regulated kinases by normal and mutant EGF receptors
Lorimer, I. A. J., & Lavictoire, S. J. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00129-4 · Cited by 41
Function of aberrant EGFR in malignant gliomas
Sugawa, N., Yamamoto, K., Ueda, S., Morita, N., Kita, M., Nishino, H., Fushiki, S., & Okabe, T. (1998) · Brain Tumor Pathology · doi:10.1007/bf02482101 · Cited by 40
A novel small molecule that selectively inhibits glioblastoma cells expressing EGFRvIII
Trembath, D. G., Lal, A., Kroll, D. J., Oberlies, N. H., & Riggins, G. J. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-30 · Cited by 26
Cited by
EGF receptor trafficking: consequences for signaling and cancer
Tomas, A., Futter, C. E., & Eden, E. R. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.11.002 · Cited by 779
Targeting the ERBB family in cancer: couples therapy
Tebbutt, N., Pedersen, M. W., & Johns, T. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3559 · Cited by 466
The epidermal growth factor receptor variant III (EGFR v III): where wild things are altered
Gan, H. K., Cvrljevic, A. N., & Johns, T. G. (2013) · The FEBS Journal · doi:10.1111/febs.12393 · Cited by 370
Self-citationPrognostic and Predictive Biomarkers in Gliomas
Śledzińska, P., Bebyn, M. G., Furtak, J., Kowalewski, J., & Lewandowska, M. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910373 · Cited by 340
Glioblastoma Multiforme: An Overview of Emerging Therapeutic Targets
Taylor, O. G., Brzozowski, J. S., & Skelding, K. A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00963 · Cited by 322
Metadata
- Authors
- Gan, H. K., Kaye, A. H., & Luwor, R. B.
- Venue
- Journal of Clinical Neuroscience
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 16
- Issue
- 6
- Pages
- 748-754
- ISSN
- 0967-5868 (ISSN-L)
- OpenAlex
- W2064876412
- Cited by
- 396
- References
- 93
- FWCI
- 13.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.